{"url_path":"/sec/calc/8-k/2026-06-24/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-24","source_url":"https://www.sec.gov/Archives/edgar/data/1534133/0001193125-26-280223-index.html","accession_number":"0001193125-26-280223","cik":"0001534133","ticker":"CALC","issuer_name":"CalciMedica, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1534133/0001193125-26-280223-index.html","primary_entity_key":"0001534133","primary_entity_name":"CalciMedica, Inc."},"word_count":168,"has_tables":true,"body_markdown":"Item 9.01 Financial Statements and Exhibits\n\n(d) Exhibits\n\n \n\nExhibit\nNo.\n  \n\nDescription\n\n4.1\n  \n[Form of Pre-Funded Warrant](d40651dex41.htm)\n\n4.2\n  \n[First Amendment to Warrant to Purchase Shares of Stock dated June 23, 2026, by and between CalciMedica, Inc. and Avenue Venture Opportunities Fund II, L.P.](d40651dex42.htm)\n\n4.3\n  \n[First Amendment Warrant to Purchase Shares of Stock of CalciMedica, Inc. dated June 23, 2026, by and between CalciMedica, Inc., Avenue Venture Opportunities Fund II, L.P. and Avenue Capital Management II, L.P.](d40651dex43.htm)\n\n10.1\n  \n[First Amendment to Loan Documents dated June 23, 2026, by and between CalciMedica, Inc., Avenue Venture Opportunities Fund II, L.P. and Avenue Capital Management II, L.P.](d40651dex101.htm)\n\n104\n  \nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \nCalciMedica, Inc.\n\nDate: June 24, 2026\n \n\n \nBy:\n \n\n/s/ A. Rachel Leheny, Ph.D.\n\n \n\n \nName:\n \nA. Rachel Leheny, Ph.D.\n\n \n\n \nTitle:\n \nChief Executive Officer"}